SEMCAP Food & Nutrition has successfully closed its inaugural fund with $125 million in commitments from strategic investors including Fresh Del Monte, Farm Credit Canada, and Securian Financial. The fund brings SEMCAP's total assets under management to over $500 million, with existing investments in companies like ALOHA, Kite Hill, and Good Culture, positioning the firm to expand its portfolio of sustainable food and nutrition brands across North America.

The U.S. processed pumpkin market is projected to grow from $1.43 billion in 2024 to $3.34 billion by 2033, driven by health trends, seasonal demand, and versatile food applications.

Fresh Del Monte Produce reported strong Q2 2025 financial results, with non-GAAP EPS of $1.23, exceeding analyst expectations. The company saw 3.8% revenue growth and improved performance in fresh and value-added product segments, driven by higher selling prices and innovative product lines.

The global fresh vegetable market is projected to reach $1.6 trillion by 2034, driven by shifting consumer preferences, sustainability concerns, and technological advancements in agriculture. Key players in the industry include Fresh Del Monte Produce, Dole, and Conagra Brands.

The global superfood market is expected to grow at a CAGR of 4.41% from 2025 to 2033, driven by increasing health consciousness and demand for nutrient-dense foods. The market is growing across all regions, with North America leading the way.

The Upcycled Certified program, which verifies sustainable food production practices, has seen a 17% year-over-year increase in certifications in 2024. The number of participating companies has grown to 105, including major brands like Del Monte, Kerry, and Hershey-backed Blue Stripes, diverting 1.2 million tons of food waste in the US.

Dandy® Produce, a leading grower of fresh celery, radish and corn in the U.S., highlights the hydration benefits of celery and celery juice as a healthy alternative to water during the hot summer months.

Style Box ETF report for XSVM

Fresh Del Monte’s stock fell Monday, after the fresh fruit and vegetable producer missed fourth-quarter earnings expectations, as lower banana sales were offset by higher prices of most products, such as avocados and pineapples.

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. The Vita Coco Company, Inc. (NASDAQ: COCO) On Jan. 31, Goldman Sachs analyst Bonnie Herzog maintained Vita Coco with a Buy and lowered the price target from $32 to $28. The company’s stock fell around 21% over the past month and has a 52-week low of $13.40 . RSI Value: 25.44 COCO Price Action: Shares of Vita Coco fell 1.7% to close at $19.61 on Monday. MGP Ingredients, Inc. (NASDAQ: MGPI) On Jan. ...

Style Box ETF report for XSVM

Gainers Cellectis S.A. (NASDAQ: CLLS) shares jumped 136% to $2.2799. Cellectis reported strategic collaboration and investment agreements with AstraZeneca. Cellectis also presented pre-clinical data on multi-armored allogeneic MUC1-CAR T-cells targeting triple-negative breast cancer at the Society for Immunotherapy of Cancer 38th Annual Meeting. Patriot Transportation Holding, Inc. (NASDAQ: PATI) climbed 104.8% to $15.73. Patriot Transportation announced an agreement under which United Petroleum Transports will acquire all of the outstanding shares of Patriot common stock for $16.26 per share in cash. Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) gained 33% to $2.2780. Aldeyra Therapeutics entered into an exclusive option agreement with AbbVie Inc. ShiftPixy, Inc. (NASDAQ: PIXY) climbed 30% to $6.82. Monopar Therapeutics Inc. (NASDAQ: MNPR) shares rose 29% to $0.5782. Monopar presented data showing tumor reduction benefit of camsirubicin from ongoing Phase 1b in patients with advanced soft tissue sarcoma at the 2023 Connective Tissue Oncology Society Annual Meeting. TG Therapeutics, Inc. (NASDAQ: TGTX) climbed 26.8% to $9.80 following third-quarter results. MSP Recovery, Inc. (NASDAQ: LIFW) gained 25% to $3.08. On Monday, the company announced that it is in compliance with all applicable Nasdaq listing standards. ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) climbed 20% to $0.0984. ZyVersa Therapeutics announced publication in molecular neurobiology reinforcing data demonstrating that inflammasome ASC inhibitor IC 100 attenuates the inflammatory response causing neuronal damage in multiple sclerosis model. EUDA Health Holdings Limited (NASDAQ: EUDA) rose 18.6% to $1.02. GDEV Inc. (NASDAQ: GDEV) shares gained 16.2% to $2.35 after falling 11% on Tuesday. Maison Solutions Inc. (NASDAQ: MSS) climbed 14.5% to $6.31. Generac Holdings Inc. (NYSE: GNRC) gained 13.7% to $95.60 following upbeat earnings. Mercury General Corporation (NYSE: MCY) gained 13.5% to $35.04 following quarterly results. Davis Commodities Limited (NASDAQ: DTCK) rose 13.4% to $4.1850. Newmark Group, Inc. (NASDAQ: NMRK) gained 13.4% to ...